Vanderbilt Center for Addiction Research.
Department of Molecular Physiology and Biophysics.
J Neurosci. 2018 Oct 17;38(42):8922-8942. doi: 10.1523/JNEUROSCI.0963-18.2018. Epub 2018 Aug 27.
Stress is a precipitating agent in neuropsychiatric disease and initiates relapse to drug-seeking behavior in addicted patients. Targeting the stress system in protracted abstinence from drugs of abuse with anxiolytics may be an effective treatment modality for substance use disorders. α-adrenergic receptors (α-ARs) in extended amygdala structures play key roles in dampening stress responses. Contrary to early thinking, α-ARs are expressed at non-noradrenergic sites in the brain. These non-noradrenergic α-ARs play important roles in stress responses, but their cellular mechanisms of action are unclear. In humans, the α-AR agonist guanfacine reduces overall craving and uncouples craving from stress, yet minimally affects relapse, potentially due to competing actions in the brain. Here, we show that heteroceptor α-ARs postsynaptically enhance dorsal bed nucleus of the stria terminalis (dBNST) neuronal activity in mice of both sexes. This effect is mediated by hyperpolarization-activated cyclic nucleotide-gated cation channels because inhibition of these channels is necessary and sufficient for excitatory actions. Finally, this excitatory action is mimicked by clozapine--oxide activation of the G-coupled DREADD hM4Di in dBNST neurons and its activation elicits anxiety-like behavior in the elevated plus maze. Together, these data provide a framework for elucidating cell-specific actions of GPCR signaling and provide a potential mechanism whereby competing anxiogenic and anxiolytic actions of guanfacine may affect its clinical utility in the treatment of addiction. Stress affects the development of neuropsychiatric disorders including anxiety and addiction. Guanfacine is an α2A-adrenergic receptor (α2A-AR) agonist with actions in the bed nucleus of the stria terminalis (BNST) that produces antidepressant actions and uncouples stress from reward-related behaviors. Here, we show that guanfacine increases dorsal BNST neuronal activity through actions at postsynaptic α2A-ARs via a mechanism that involves hyperpolarization-activated cyclic nucleotide gated cation channels. This action is mimicked by activation of the designer receptor hM4Di expressed in the BNST, which also induces anxiety-like behaviors. Together, these data suggest that postsynaptic α2A-ARs in BNST have excitatory actions on BNST neurons and that these actions can be phenocopied by the so-called "inhibitory" DREADDs, suggesting that care must be taken regarding interpretation of data obtained with these tools.
压力是神经精神疾病的诱发因素,并引发成瘾患者对觅药行为的复发。使用抗焦虑药靶向滥用药物延长戒断期间的应激系统可能是治疗物质使用障碍的有效治疗方式。在扩展的杏仁核结构中,α-肾上腺素能受体 (α-ARs) 在抑制应激反应中起关键作用。与早期的想法相反,α-ARs 在大脑中的非去甲肾上腺素能部位表达。这些非去甲肾上腺素能的 α-ARs 在应激反应中发挥重要作用,但它们的细胞作用机制尚不清楚。在人类中,α-AR 激动剂胍法辛可降低整体渴望并使渴望与压力脱钩,但对复发的影响最小,这可能是由于大脑中的竞争作用。在这里,我们表明,异性 α-AR 在后突触增强雄性和雌性小鼠背侧终纹床核 (dBNST) 神经元的活性。这种作用是由 hyperpolarization-activated cyclic nucleotide-gated cation channels 介导的,因为抑制这些通道对于兴奋作用是必要和充分的。最后,clozapine-oxide 通过 dBNST 神经元中的 G 偶联 DREADD hM4Di 激活来模拟这种兴奋作用,其激活在高架十字迷宫中引起焦虑样行为。总之,这些数据为阐明 GPCR 信号的细胞特异性作用提供了一个框架,并提供了一个潜在的机制,说明胍法辛的竞争焦虑和抗焦虑作用可能会影响其在治疗成瘾中的临床应用。压力会影响神经精神疾病的发展,包括焦虑和成瘾。胍法辛是一种作用于终纹床核 (BNST) 的 α2A-肾上腺素能受体 (α2A-AR) 激动剂,可产生抗抑郁作用,并使压力与奖赏相关行为脱钩。在这里,我们表明,胍法辛通过涉及 hyperpolarization-activated cyclic nucleotide gated cation channels 的机制,通过突触后 α2A-AR 增加背侧 BNST 神经元的活性。该作用可被表达在 BNST 中的设计受体 hM4Di 的激活模拟,其也诱导焦虑样行为。总之,这些数据表明 BNST 中的突触后 α2A-AR 对 BNST 神经元具有兴奋作用,并且这些作用可以被所谓的“抑制性”DREADDs 模拟,这表明在使用这些工具获得的数据的解释中必须谨慎。